Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia

被引：7
|
作者：
Bassler, Dirk [1 ]
van den Anker, John [2 ,3 ]
机构：
[1] Univ Zurich, Univ Hosp Zurich, Dept Neonatol, Frauenklin Str 10, CH-8091 Zurich, Switzerland
[2] Univ Basel, Div Paediat Pharmacol & Pharmacometr, Childrens Hosp, Spitalstr 33, CH-4056 Basel, Switzerland
[3] Childrens Natl Med Ctr, Div Clin Pharmacol, 111 Michigan Ave NorthWest, Washington, DC 20010 USA
来源：
PEDIATRIC CLINICS OF NORTH AMERICA | 2017年 / 64卷 / 06期
关键词：
Bronchopulmonary dysplasia; Inhaled corticosteroids; Inhaled bronchodilators; Systemic corticosteroids; Dexamethasone; Hydrocortisone; Pharmacology; CHRONIC LUNG-DISEASE; LOW-DOSE HYDROCORTISONE; PRETERM INFANTS; PREMATURE-INFANTS; RANDOMIZED-TRIAL; CEREBRAL-PALSY; DOUBLE-BLIND; PREVENTION; THERAPY; PHARMACOKINETICS;
D O I：
10.1016/j.pcl.2017.08.012
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
All definitions of bronchopulmonary dysplasia (BPD) have limitations, and a new definition for the purpose of clinical research, benchmarking, and prognostic prediction is needed. Different inhaled and systemic drugs are currently used to prevent or treat BPD. Despite some positive effects on BPD, more information about the effects of inhaled corticosteroids is required to assess overall efficacy and associated risks. One needs to balance the risks of neurodevelopmental impairment owing to systemic corticosteroids against those of BPD itself. Future studies should, therefore, focus on infants with a very high risk of developing BPD and include pharmacokinetics and long-term developmental outcomes.
引用
收藏
页码：1355 / +
页数：14
相关论文
共 50 条
  • [1] Inhaled corticosteroids and bronchopulmonary dysplasia
    Isaacs, David
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, 54 (12) : 1399 - 1399
  • [2] INHALED CORTICOSTEROIDS IN SEVERE BRONCHOPULMONARY DYSPLASIA (BPD)
    DUNN, MS
    MAGNANI, L
    BELAICHE, M
    PEDIATRIC RESEARCH, 1989, 25 (04) : A213 - A213
  • [3] Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
    Slaughter, Jonathan L.
    Stenger, Michael R.
    Reagan, Patricia B.
    Jadcherla, Sudarshan R.
    PLOS ONE, 2014, 9 (09):
  • [4] Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis
    Shinwell, Eric S.
    Portnov, Igor
    Meerpohl, Joerg J.
    Karen, Tanja
    Bassler, Dirk
    PEDIATRICS, 2016, 138 (06)
  • [5] INHALED CORTICOSTEROIDS FOR BRONCHOPULMONARY DYSPLASIA: A META-ANALYSIS
    Shinwell, E. S.
    Portnov, I.
    Meerpohl, J. J.
    Karen, T.
    Bassler, D.
    ACTA PAEDIATRICA, 2017, 106 : 26 - 26
  • [6] Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia
    Pantalitschka, T.
    Poets, C. F.
    PEDIATRIC PULMONOLOGY, 2006, 41 (08) : 703 - 708
  • [7] Corticosteroids in bronchopulmonary dysplasia
    Mellis, Craig
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2019, 55 (09) : 1148 - 1148
  • [8] Corticosteroids in bronchopulmonary dysplasia
    Mellis, Craig
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2019, 55 (05) : 607 - 608
  • [9] Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates
    Shah, S. S.
    Ohlsson, A.
    Halliday, H. L.
    Shah, V. S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (10):
  • [10] Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants
    Shah, S. S.
    Ohlsson, A.
    Halliday, H. L.
    Shah, V. S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (10):
12345